OVERVIEW
The global market for transplant diagnostics is expected to reach USD 5.21 billion by 2024, growing over the forecast period at a CAGR of 7.4%. The growth of transplant diagnostics market is primarily driven by increasing public-private funding for target research programs, rising infectious disease burden, increasing number of transplant procedures, and technological advances in transplant diagnostics.
TABLE OF CONTENT
1 Global Transplant Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Transplant Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Transplant Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Transplant Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Transplant Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Transplant Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Transplant Diagnostics Market – By Technology (Market Size – & million/billion)
8.1 Molecular Assay Technologies
8.2 Non-molecular Assay Technologies
9 Global Transplant Diagnostics Market – By Product & Service
9.1 Reagents & Consumables
9.2 Instruments
9.3 Software & Services
10 Global Transplant Diagnostics Market – By Transplant Type
10.1 Solid Organ Transplantation
10.2 Stem Cell Transplantation
10.3 Soft Tissue Transplantation
10.4 Bone marrow Transplantation
11 Global Transplant Diagnostics Market – By Application
11.1 Diagnostic Applications
11.2 Research Applications
12 Global Transplant Diagnostics Market – By End-User
12.1 Independent Reference Laboratories
12.2 Hospitals & Transplant Centers
12.3 Research Laboratories & Academic Institutes
13 Global Transplant Diagnostics Market – By Geography (Market Size – & million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa
14 Global Transplant Diagnostics Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships
15 Global Transplant Diagnostics Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Becton, Dickinson and Company
15.3 Biofortuna
15.4 Biomérieux SA
15.5 Bio-Rad Laboratories
15.6 Caredx
15.7 Illumina, Inc.
15.8 Gendx
15.9 Immucor, Inc.
15.10 F. Hoffman-La Roche Limited
15.11 Hologic, Inc.
15.12 Company 11 & more
16 Global Transplant Diagnostics Market – Appendix
16.1 Sources
16.2 Abbreviations